Eradication of MRSA in patients with chronic skin lesions

Eradication of MRSA in patients with chronic skin lesions - MEracL

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00004597

Enrollment

200

Registered

2013-01-07

Start date

2012-06-21

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L97 L89.9 U80.0 T88.9

Interventions

Group 1: structured software-based treatment (Jalomed WD (R)) of chronic wound colonized with MRSA, measurement of quality of life by SF12 questionnaire Group 2: structured software-based treatment (J

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with chronic skin lesions, informed consent

Exclusion criteria

Exclusion criteria: chronic skin lesions colonised by other multiresistant bacteria, denial of informed consent, noncompliance, intolerance to eradication medicine, a repeated cycle of eradication according to study protocol

Design outcomes

Primary

Measure	Time frame
Rate of wound closure measured by medical software (Jalomed WD)	—

Secondary

Measure	Time frame
Decolonisation rate of MRSA after 12 months, Quality of life by SF12 questionnaire after inclusion and after 6 months, economic evaluation of the additional effort by time measurement	—

Countries

Germany

Contacts

Public ContactKathleen Dittmann

Institut für Hygiene und Umweltmedizin Universitätsmedizin Greifswald

kathleen.dittmann@uni-greifswald.de03834 515597

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026